Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Hiligsmann

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Patient|January 11, 2023
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in EuropeDamon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, et al.
Frontiers in Pharmacology|January 7, 2025
Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty yearsPrzemyslaw Kardas, Bryan Bennett, Bijan Borah, et al.
Pharmacoeconomics|October 7, 2020
The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best-Worst Scaling ExperimentIrina Pokhilenko, Luca M M Janssen, Mickael Hiligsmann, et al.
BMC Health Services Research|February 16, 2018
Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional studyPuttarin Kulchaitanaroaj, Zoltán Kaló, Robert West, et al.
Current Diabetes Reports|July 21, 2025
Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public HealthcareLakshmi Nagendra, Khushboo Agarwal, Shinjan Patra, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 11, 2020
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition ModelIngrid E H Kremer, Mickael Hiligsmann, Josh Carlson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 4, 2015
Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributesBen Fm Wijnen, Inge M van der Putten, Siebren Groothuis, et al.
Pharmacoeconomics|October 19, 2021
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Willem Witlox, Robert Wolff, et al.
Seminars in Arthritis and Rheumatism|June 17, 2021
Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group<sup>✰</sup>Megan Thomas, Liana Fraenkel, Annelies Boonen, et al.
Calcified Tissue International|March 22, 2013
Health technology assessment in osteoporosisMickael Hiligsmann, John A Kanis, Juliet Compston, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Patient|January 11, 2023
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in EuropeDamon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, et al.
Frontiers in Pharmacology|January 7, 2025
Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty yearsPrzemyslaw Kardas, Bryan Bennett, Bijan Borah, et al.
Pharmacoeconomics|October 7, 2020
The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best-Worst Scaling ExperimentIrina Pokhilenko, Luca M M Janssen, Mickael Hiligsmann, et al.
BMC Health Services Research|February 16, 2018
Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional studyPuttarin Kulchaitanaroaj, Zoltán Kaló, Robert West, et al.
Current Diabetes Reports|July 21, 2025
Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public HealthcareLakshmi Nagendra, Khushboo Agarwal, Shinjan Patra, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 11, 2020
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition ModelIngrid E H Kremer, Mickael Hiligsmann, Josh Carlson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 4, 2015
Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributesBen Fm Wijnen, Inge M van der Putten, Siebren Groothuis, et al.
Pharmacoeconomics|October 19, 2021
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Willem Witlox, Robert Wolff, et al.
Seminars in Arthritis and Rheumatism|June 17, 2021
Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group<sup>✰</sup>Megan Thomas, Liana Fraenkel, Annelies Boonen, et al.
Calcified Tissue International|March 22, 2013
Health technology assessment in osteoporosisMickael Hiligsmann, John A Kanis, Juliet Compston, et al.
Pageof 9